Production of Human Endothelial Cells Free from Soluble Xenogeneic Antigens for Bioartificial Small Diameter Vascular Graft Endothelization

Arterial bypass graft implantation remains the primary therapy for patients with advanced cardiovascular disease, but most lack adequate saphenous vein or other conduits for bypass procedures and would benefit from a bioartificial conduit. This study aimed to produce human endothelial cells (hECs) i...

Descripción completa

Detalles Bibliográficos
Autores principales: de Carvalho, Juliana Lott, Zonari, Alessandra, de Paula, Ana Cláudia Chagas, Martins, Thaís Maria da Mata, Gomes, Dawidson Assis, Goes, Alfredo Miranda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471259/
https://www.ncbi.nlm.nih.gov/pubmed/26146626
http://dx.doi.org/10.1155/2015/652474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471259/
https://www.ncbi.nlm.nih.gov/pubmed/26146626
http://dx.doi.org/10.1155/2015/652474

Ejemplares similares